Development and validation of a new RP-HPLC method for the determination of process related impurities in pioglitazone hydrochloride
Open Access
- 30 September 2014
- journal article
- Published by European Journal of Chemistry in European Journal of Chemistry
- Vol. 5 (3), 469-474
- https://doi.org/10.5155/eurjchem.5.3.469-474.1058
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- MitoNEET is a uniquely folded 2Fe–2S outer mitochondrial membrane protein stabilized by pioglitazoneProceedings of the National Academy of Sciences of the United States of America, 2007
- Effect of thiazolidinediones on lipid profileCMAJ : Canadian Medical Association Journal, 2005
- Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobeAmerican Journal of Physiology-Endocrinology and Metabolism, 2004
- Quantitative determination of pioglitazone in human serum by direct-injection high-performance liquid chromatography mass spectrometry and its application to a bioequivalence studyJournal of Chromatography B, 2003
- Thiazolidinediones in Type 2 Diabetes MellitusDrugs, 2003
- Determination of pioglitazone hydrochloride in bulk and pharmaceutical formulations by HPLC and MEKC methodsJournal of Pharmaceutical and Biomedical Analysis, 2002
- Clinical pharmacokinetics of pioglitazoneExperimental and Clinical Endocrinology & Diabetes, 2000
- PioglitazoneDrugs, 2000
- Simultaneous quantitation of pioglitazone and its metabolites in human serum by liquid chromatography and solid phase extractionJournal of Pharmaceutical and Biomedical Analysis, 1996
- High-performance liquid chromatographic determination of pioglitazone and its metabolites in human serum and urineJournal of Chromatography B: Biomedical Sciences and Applications, 1996